Information about the production facility in which pharmaceutical formulation takes place
The purpose of this award criterion is to increase transparency and traceability when active pharmaceutical ingredients (APIs) are used in pharmaceutical formulation. Information on the location of pharmaceutical formulation for the medicinal products covered by the agreement allows contracting authorities to better identify and prioritise environmental and social risks, as well as follow-up efforts.
- Award criteria
- Medicinal Products
In order to receive [points or discounts per position], the supplier must provide information regarding where (name and address(es) of production facility) the offered medicinal product(s) are formulated. If the offered medicinal product is manufactured in more than one location, all production facilities must be listed.
If this award criterion is fulfilled, the supplier must, without delay during the contract period, notify of any changes with regard to where (name(s) and address(es) of production facility) pharmaceutical formulation takes place for the medicinal products for which the supplier has provided information.
In order to receive [points or discounts per position] in the tender evaluation, the supplier must, together with its tender, provide information regarding where (name(s) and address(es) of production facility) pharmaceutical formulation takes place for the offered medicinal products. The source of the information or where it can be accessed can vary depending on the supplier's business model or trading situation.
Ensure that the contractual terms describe how the follow-up process will be carried out and which documentation or information the supplier needs to submit and when.
When following up the agreement, the contracting authority may request that the supplier provides supporting information regarding where the contracted medicinal products are formulated. For more information, see the implementation manual.
Subject matter of contract
Procurement object. Medicinal products for Inpatient care.
Information about the criterion
This award criterion can be applied separately or together with the following additional award criteria:
· Information on the location of pharmaceutical formulation (Requirement ID 11223, advanced level)
· Information on the location of API production for medicinal products (Requirement ID 11225, advanced level)
· Information about the production facility in which APIs are manufactured for medicinal products (Requirement ID 11370, spearhead level).
A medicinal product may be manufactured at more than one geographical location and production facility. The supplier may therefore need to provide information about several production facilities, together with their addresses, in which offered medicinal product(s) are formulated.
The contracting authority may check the provided details during the evaluation of tenders. For more information, see the implementation manual.
The version date indicates when the sustainability criterion was created or last updated. Last reviewed dated tells when we last checked that the sustainability criterion still is relevant.
- Current ID
- Version date